Oncology Medication Brand/Generics

Oncology Medication Brand/Generics

Afinitor

Everolimusis an mTOR inhibitor used to treat certain types of cancer, including breast cancer and renal cell carcinoma.

Alecensa

Alectinib

Arimidex

Anastrozole - Nonsteroidal Aromatase Inhibitor

Brukinsa

zanabrutinib

Calquence

acalabrutinib - inhibits Bruton's tyrosine kinase (TKI)

Femara

Letrozole - Nonsteroidal Aromatase Inhibitor

Gleevec

Imatinib (tyrosine-kinase inhibitor)

Ibrance

Palbociclibis a medication used in the treatment of breast cancer, often in combination with hormone therapies.

Imbruvica

Ibrutinib

Inqovi

Decitabine-Cedazuridinea combination medication used to treat certain types of leukemia, improving the effectiveness of Decitabine.

Jakafi

Ruxolitinib, a JAK1 and JAK2 inhibitor used to treat certain blood disorders.

Kisqali

Ribociclib - a medication used to treat certain types of breast cancer by inhibiting specific cell growth.

Krazati

Adagrasib - used for the treatment of non-small cell lung cancer with specific genetic mutations.

Lenvima

Lenvatinib

Lynparza

Olaparib

Orgovyx

Relugolixis an oral GnRH antagonist used to treat advanced prostate cancer.

Revlimid

lenalidomide

Sprycel

Dasatinib

Tagrisso

Osimertinib - a targeted therapy used to treat non-small cell lung cancer (NSCLC) with specific mutations.

Targretin

Bexarotene - retinoid drug used for cutaneous manifestations of T-cell lymphoma in patients who have not responded well to previous systemic therapy

Tasigna

Nilotinib

Tecfidera

Dimethyl Fumarate is an oral medication used to treat multiple sclerosis by reducing the frequency of relapses.

Truqap

Capivasertib

Venclexta

Venetoclax

Vonjo

Pacritinib

Xeloda

Capecitabine

Zytiga

Abiraterone